02:31 AM EDT, 09/24/2026 (MT Newswires) -- BioPharma Credit (BPCP.L, BPCR.L) said Thursday that its return and total income declined year over year in the first half. Return for the six months ended June 30 was $50.4 million, compared with $72.8 million earlier. Net revenue and capital return per ordinary share moved to $0.0447 from $0.0633. The investment company's total income was $57.4 million, compared with $83.8 million a year ago.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.